ISLAMABAD, May 30 (Online): A phase two trial of brepocitinib, a drug being tested as a possible treatment for several immuno compromising conditions like systemic lupus erythematosus, ulcerative colitis, and dermatomyositis, has also shown positive results for the treatment of psoriatic arthritis. The trial’s results […]